Expression of dihydropyrimidine dehydrogenase (DPD) and hENT1 predicts survival in pancreatic cancer.


Halloran, CM ORCID: 0000-0002-5471-4178 (2018) Expression of dihydropyrimidine dehydrogenase (DPD) and hENT1 predicts survival in pancreatic cancer. JNCI: Journal of the National Cancer Institute, 118 (7). pp. 947-954.

[img] Text
DPD JNCI 31st May 2017.docx - Submitted version
Download (7MB)
Item Type: Article
Uncontrolled Keywords: Rare Diseases, Cancer, Digestive Diseases, Pancreatic Cancer, Clinical Research, 4.4 Population screening, 4 Detection, screening and diagnosis, Cancer, Adult, Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols, Biomarkers, Tumor, Carcinoma, Pancreatic Ductal, Deoxycytidine, Dihydrouracil Dehydrogenase (NADP), Equilibrative Nucleoside Transporter 1, Female, Fluorouracil, Humans, Immunohistochemistry, Leucovorin, Male, Middle Aged, Pancreatic Neoplasms, Prognosis, Randomized Controlled Trials as Topic, Survival Analysis, Tissue Array Analysis, Gemcitabine
Depositing User: Symplectic Admin
Date Deposited: 20 Jun 2017 09:44
Last Modified: 20 Apr 2024 02:41
DOI: 10.1038/s41416-018-0004-2
URI: https://livrepository.liverpool.ac.uk/id/eprint/3007931
Dimensions
Altmetric
CORE (COnnecting REpositories)